Scientists investigate mysterious immune disease to find better ways to diagnose it
NCT ID NCT06339177
First seen Dec 10, 2025 · Last updated May 04, 2026 · Updated 24 times
Summary
This study aims to understand why some adults develop a severe immune condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which causes dangerous fevers and inflammation. Researchers will follow 300 adults with sHLH for up to a year, collecting blood samples and medical information. No new treatments are given; the goal is to find better ways to diagnose and manage the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACROPHAGE ACTIVATION SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15261, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.